Torrent Pharmaceutical Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC
New Delhi: Reviewing the justification presented by the drug major Torrent Pharmaceutical, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to manufacture and market the fixed-dose combination (FDC) Alogliptin Benzoate eq. to Alogliptin 25mg/25mg plus Pioglitazone Hydrochloride USP eq. to Pioglitazone 15mg/30mg film-coated tablet. This came […]
